#Comoros started its COVID-19 vaccination drive on Saturday, with President Azali Assoumani the first to be inoculated with a jab of China's Sinopharm vaccine.
A new recombinant COVID-19 vaccine developed by China's Sinopharm has been approved for clinical trials by the country's drug regulator, the developer said on Saturday.
The subsidiary of state-owned Sinopharm says that manufacturing the candidate, which is based on protein cultivated in factories, does not require facilities with high biosafety levels.
A recombinant COVID-19 vaccine of China's vaccine developer Sinopharm has been approved for clinical trials, the company said Saturday. So far, the company has two types of inactivated COVID-19 vaccines being put into use.
"...
-working to accelerate the release and rollout of #COVID19 vaccines from SK Bio in
-trying to expedite the delivery of the J&J vaccine
-expediting the review of more vaccines including from Sinopharm, Sinovac & Gamaleya
... " @DrTedros- #VaccinEquity
#China ’s Sinopharm increased it #COVID19 vaccine production capacity to 100 million doses per month since April, with it #Wuhan institute aiming to increase annual production capacity to 1 billion doses in near future.
"I would like to thank the state of #China , its leadership, government and people, for their great solidarity with us in this crisis," Egyptian Health Minister Hala Zayed said on Thursday in Cairo, adding #Egypt has received two batches of China's Sinopharm vaccines recently.
"I would like to thank the state of China, its leadership, government and people, for their great solidarity with us in this crisis," Egyptian Health Minister Hala Zayed said on Thursday in Cairo, adding Egypt has received two batches of China's Sinopharm vaccines recently.
Loading
Reassuring new data for 2 inactivated virus vaccines, Sinovac and Sinopharm, developed in China (no 2-P substitution), now in wide use, against both the B.1.1.7 (UK) and B.1.351 (SA) variants @NEJM
JUST IN: The United Arab Emirates will start producing China’s Sinopharm vaccine next month in a deal that deepens Beijing’s influence in the Arab Gulf, long a bastion of U.S. power
JUST IN: China's Sinopharm says its coronavirus vaccine is 79% effective
JUST IN: China approves Sinopharm's coronavirus vaccine
Taiwan news report claims Sinopharm has 73 side effects; PH experts weigh in
A Taiwanese news website recently claimed that the #COVID19 vaccine of Chinese firm Sinopharm is being called the “most unsafe in the world.” The vaccine was reportedly used to inoculate members of PSG despite not yet being approved for use in PH. READ:
Chinese regulators have approved a coronavirus vaccine developed by state-owned pharmaceutical giant Sinopharm, officials have announced
Batch of updates for the @nytimes coronavirus vaccine tracker: Sinopharm Phase III trial on inactivated virus in UAE. Genexine: Phase I DNA-based vaccine trial. Anhui Zhifei: Phase I inactivated virus. AstraZeneca: Phase III vector trial in South Africa
Loading